Individualized physical activity and diet: Precision health
Study summary
The aim of this pilot randomized controlled trial LI-PAD is to identify whether a 6-month intervention approach to individually optimize lifestyle behavior, physical activity, and diet, is feasible and leads to larger improvements in body weight, cardiovascular disease risk factors, and health-related quality of life compared to simple written lifestyle advice, in individuals with overweight or obesity.
The intervention group will be offered individual support for lifestyle behavioral change (precision health) and the control group will be offered written lifestyle advice, following national recommendations. In total, 60 population-based participants and 60 controls from the Gothenburg area, aged 45-65 years, will be recruited.
Eligibility
Sex
ALL
Min age
45 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
* Age 45-65 years
* A body mass index (BMI) of ≥28 and \<35
Exclusion Criteria:
* Known coronary artery disease (clinical symptoms/earlier event)
* Other contraindications such as inability to understand language or unable to perform lifestyle interventions
Primary outcome measure(s)
Change in body weight 1 — From baseline to 6 months Reduction in body weight (kg) in percent will be identified by using Lidén weighing scale.
Change in body weight 2 — From baseline to 1 month (intervention group) Reduction in body weight (kg) in percent will be identified by using Lidén weighing scale. Less weight at the 1-month follow-up than at baseline is a better outcome than vice versa.
Change in body weight 3 — From 1 month to 3 months (intervention group) Reduction in body weight (kg) in percent will be identified by using Lidén weighing scale. Less weight at the 3-month follow-up than at the 1-month follow-up is a better outcome than vice versa.
Change in body weight 4 — From 3 months to 6 months (intervention group) Reduction in body weight (kg) in percent will be identified by using Lidén weighing scale.
Less weight at the 6-month follow-up than at the 3-month follow-up is a better outcome than vice versa.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.